GI & Endoscopy

Researchers at Barcelona, Spain-based Hospital Del Mar Medical Research Institute discovered inhibiting the Jagged 1 protein in mice prevents colon and rectal tumor growth, according to research published in Nature Communications.

Here are the five most popular gastroenterology and endoscopy stories for the week of July 26 to August 1, 2018.

Takeda released its first quarter 2018 revenue numbers.

The American College of Gastroenterology released new recommendations for the treatment and management of Crohn's disease in adults, Medscape reported.

Researchers in Canada found using steroids before ulcerative colitis surgery is associated with a higher risk for postoperative sepsis and clotting, Gastroenterology & Endoscopy news reported.

Exact Sciences posted $102.9 million in second quarter 2018 revenue, missing investor predictions by $1.8 million, or 1.7 percent, causing its stock to fall 18.75 percent.

Exact Sciences released its second-quarter earnings Aug. 1, posting revenues of $102.9 million.

Mary A. Atia, MD, is a gastroenterologist at Glendale-based Arizona Digestive Health.

Here are six updates on GI companies from the past week:

It's estimated up to 5 million people in the U.S. are affected by gastroparesis, according to the International Foundation for Functional Gastrointestinal Disorders. To bring light to the condition, the IFFGD established Gastroparesis Awareness Month in 2016 to take place…